Lenalidomide in treatment-refractory cutaneous lupus erythematosus: Efficacy and safety in a 52-week trial Lauren Okon, MD, Misha Rosenbach, MD, Michael Krathen, MD, Mathew Rose, MS, Kathleen Propert, ScD, Joyce Okawa, RN, Victoria Werth, MD Journal of the American Academy of Dermatology Volume 70, Issue 3, Pages 583-584 (March 2014) DOI: 10.1016/j.jaad.2013.11.007 Copyright © 2013 American Academy of Dermatology, Inc. Terms and Conditions
Fig 1 Discoid lupus. Patient 1's discoid lupus lesions at week 0 (A) and week 24 (B). Journal of the American Academy of Dermatology 2014 70, 583-584DOI: (10.1016/j.jaad.2013.11.007) Copyright © 2013 American Academy of Dermatology, Inc. Terms and Conditions